Karma Ambispective Study

计划入组 100 人 · 首次发布于 2025 年 10 月 3 日

KetAmine and Recovery After Mechanical VentilAtion ( KARMA )

计划入组 640 人 · 首次发布于 2026 年 5 月 15 日

KARMA Kontrast Evaluating Contrast Enhanced Mammography in Early Detection of Breast Cancer

计划入组 300 人 · 首次发布于 2020 年 10 月 8 日

Glycopyranosyl lipid adjuvant (Revelation Biosciences)

Gut-Restricted TGF-Beta Receptor 1 Kinase Inhibitor (Enveda Biosciences)

PIN1(Larkspur Biosciences)

AURA BIOSCIENCES

India

Assembly Biosciences

United States

EUROMI BIOSCIENCES

France

Karma Biosciences Files Patents for Rapid-Acting Nasal PDE-5 Inhibitors with 5-Minute Onset

FDA Grants Orphan Drug Designation to Pilatus Biosciences' PLT012 for Liver and Bile Duct Cancer

Tyra Biosciences Advances FGFR Inhibitor Pipeline with Multiple Clinical Trials